Erectile Dysfunction Drugs Market Expected To Encourage Expansion At USD 3.2 Billion By 2022 : Grand View Research Inc.
San Francisco, 30 July 2019: The Report Erectile Dysfunction Drugs Market Analysis By Product (Viagra, Levitra/Staxyn, Stendra/Spedra, Zydena, Vitaros), And Segment Forecasts To 2022 The global erectile dysfunction drugs market is expected to reach USD 3.2 billion by 2022 according to a new report by Grand View Research Inc. Rising adoption of sedentary lifestyle and increasing prevalence of conditions causing erectile dysfunction such as stress, hypertension, and related medications are the key factors expected to widen the target population base for this market. However, the market is estimated to witness decline in revenue over the forecast period. Expiration of key drugs from 2017 to 2019 is likely to curb revenue growth. On the other hand, the market is likely to open up new avenues for the generic manufacturers to capitalize on. The increasing risk of sexually transmitted diseases, narrowing of insurance coverage for erectile dysfunction treatment, growing threat from